Digital health technologies have brought a number of significant breakthroughs to clinical trial programs, including faster patient recruitment, more efficient data collection, and better tracking of biometric information. But the new technologies also introduce several complicated legal issues. Jones Day partners Maureen Bennett and Cristiana Spontoni talk about privacy concerns, security measures, changes to the informed consent process, data integrity, and the integration of third-party technologies to regulatory protocols.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.